131 related articles for article (PubMed ID: 12401512)
1. Neural crest cell motility in valproic acid.
Fuller LC; Cornelius SK; Murphy CW; Wiens DJ
Reprod Toxicol; 2002; 16(6):825-39. PubMed ID: 12401512
[TBL] [Abstract][Full Text] [Related]
2. Effect of valproic acid on the formation and migration of cranial neural crest cells at the early developmental stages in rat embryos.
Suzuki R; Imai H
Congenit Anom (Kyoto); 2024 Mar; 64(2):47-60. PubMed ID: 38403785
[TBL] [Abstract][Full Text] [Related]
3. Isotretinoin alters morphology, polarity, and motility of neural crest cells in culture.
Orris AS; Banicky LC; Wiens DJ
Reprod Toxicol; 1999; 13(1):45-52. PubMed ID: 10080299
[TBL] [Abstract][Full Text] [Related]
4. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation rescues valproic acid-induced developmental neurotoxicity and behavioral alterations in zebrafish embryos.
Muhsen M; Youngs J; Riu A; Gustafsson JÅ; Kondamadugu VS; Garyfalidis E; Bondesson M
Epilepsia; 2021 Jul; 62(7):1689-1700. PubMed ID: 33997963
[TBL] [Abstract][Full Text] [Related]
6. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.
Walmod PS; Foley A; Berezin A; Ellerbeck U; Nau H; Bock E; Berezin V
Cell Motil Cytoskeleton; 1998; 40(3):220-37. PubMed ID: 9678666
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
Tung EW; Winn LM
Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
[TBL] [Abstract][Full Text] [Related]
8. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
Hsieh CL; Wang HE; Tsai WJ; Peng CC; Peng RY
Toxicology; 2012 Jan; 291(1-3):32-42. PubMed ID: 22051200
[TBL] [Abstract][Full Text] [Related]
9. Glial growth factor-2 promotes the survival, migration and bromodeoxyuridine incorporation of mammalian neural crest cells in caudal neural tube explant cultures.
Bannerman PG; Puhalla S; Sahai A; Shieh A; Berman M; Pleasure D
Brain Res Dev Brain Res; 2000 Nov; 124(1-2):93-9. PubMed ID: 11113516
[TBL] [Abstract][Full Text] [Related]
10. Imidacloprid Exposure Suppresses Neural Crest Cells Generation during Early Chick Embryo Development.
Wang CJ; Wang G; Wang XY; Liu M; Chuai M; Lee KK; He XS; Lu DX; Yang X
J Agric Food Chem; 2016 Jun; 64(23):4705-15. PubMed ID: 27195532
[TBL] [Abstract][Full Text] [Related]
11. The Phosphorylation State of GSK3β Serine 9 Correlated to the Development of Valproic Acid-Associated Fetal Cardiac Teratogenicity, Fetal VPA Syndrome, Rescued by Folic Acid Administration.
Yu WH; Ho YL; Huang PT; Chu SL; Tsai HJ; Liou HH
Cardiovasc Toxicol; 2016 Jan; 16(1):34-45. PubMed ID: 25724324
[TBL] [Abstract][Full Text] [Related]
12. EMT is the major target for okadaic acid-suppressed the development of neural crest cells in chick embryo.
Jiao YH; Liu M; Wang G; Li HY; Liu JS; Yang X; Yang WD
Ecotoxicol Environ Saf; 2019 Sep; 180():192-201. PubMed ID: 31085430
[TBL] [Abstract][Full Text] [Related]
13. Effects of the antiepileptic drug valproic acid on the development of the axolotl (Ambystoma mexicanum): histological investigations.
Krätke R; Kirschbaum F
Teratog Carcinog Mutagen; 1996; 16(3):149-67. PubMed ID: 8983118
[TBL] [Abstract][Full Text] [Related]
14. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo.
Tierney BJ; Ho T; Reedy MV; Brauer PR
Dev Dyn; 2004 Jan; 229(1):63-73. PubMed ID: 14699578
[TBL] [Abstract][Full Text] [Related]
16. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
17. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid teratogenicity: a toxicogenomics approach.
Kultima K; Nyström AM; Scholz B; Gustafson AL; Dencker L; Stigson M
Environ Health Perspect; 2004 Aug; 112(12):1225-35. PubMed ID: 15345369
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen species.
Na L; Wartenberg M; Nau H; Hescheler J; Sauer H
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):174-80. PubMed ID: 12797459
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton.
Walmod PS; Skladchikova G; Kawa A; Berezin V; Bock E
Cell Motil Cytoskeleton; 1999; 42(3):241-55. PubMed ID: 10098937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
